Evidence map›Paper›PMID 31293713›Full record

ReviewWorld journal of stem cells2019

Dysfunctional stem and progenitor cells impair fracture healing with age.

Diane R Wagner, Sonali Karnik, Zachary J Gunderson, Jeffery J Nielsen, Alanna Fennimore, Hunter J Promer, Jonathan W Lowery, M Terry Loghmani, Philip S Low, Todd O McKinley and 3 more

Open access · bronzeAbstract readReview
In one paragraph

Review in World journal of stem cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Mesenchymal Stem Cell Senescence and Osteogenesis.Medicina (Kaunas, Lithuania) · 2021
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 1 country.

Diane R WagnerDepartment of Mechanical and Energy Engineering, Indiana University-Purdue University Indianapolis, Indianapolis, IN 46202, United States. wagnerdi@iupui.edu.
Sonali KarnikDepartment of Mechanical and Energy Engineering, Indiana University-Purdue University Indianapolis, Indianapolis, IN 46202, United States.
Zachary J GundersonDepartment of Orthopaedic Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, United States.
Jeffery J NielsenDepartment of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 47907, United States.
Alanna FennimoreDepartment of Physical Therapy, Indiana University-Purdue University Indianapolis, Indianapolis, IN 46202, United States.
Hunter J PromerDivision of Biomedical Science, Marian University College of Osteopathic Medicine, Indianapolis, IN 46222, United States.
Jonathan W LoweryDivision of Biomedical Science, Marian University College of Osteopathic Medicine, Indianapolis, IN 46222, United States.
M Terry LoghmaniDepartment of Physical Therapy, Indiana University-Purdue University Indianapolis, Indianapolis, IN 46202, United States.
Philip S LowDepartment of Chemistry, Purdue University, West Lafayette, IN 47907 United States.
Todd O McKinleyDepartment of Orthopaedic Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, United States.
Melissa A KacenaDepartment of Orthopaedic Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, United States.
Matthias ClaussDepartment of Medicine, Indiana University School of Medicine, Indianapolis, IN 46202, United States.
Jiliang LiDepartment of Biology, Indiana University-Purdue University Indianapolis, Indianapolis, IN 46202, United States.
Indiana University – Purdue University Indianapolis · USMarian University - Indiana · USPurdue University West Lafayette · USUniversity of Indianapolis · USIndiana University School of Medicine

Funding

Angiogenic Therapy: Novel Approaches to Enhance Bone Regeneration in Aging - LOADR01AG060621 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI KACENA, MELISSA A, LI, JILIANG · 2019 to 2023
$3.7M
Photo-Initiated Cartilage Crosslinking as a Preventative for Post-Traumatic OsteoarthritisR01AR069657 · NIAMS · INDIANA UNIVERSITY INDIANAPOLIS · PI WAGNER, DIANE · 2016 to 2020
$1.3M
Impact of TPO Treatment on Bone Healing and Angiogenesis in Type 2 DiabetesI01BX003751 · VA · RLR VA MEDICAL CENTER · PI KACENA, MELISSA A · 2017 to 2021
–
BLRD VA I01 BX003751NIAMS NIH HHS R01 AR069657NIA NIH HHS R01 AG060621
6 · The paper itself

Abstract

Successful fracture healing requires the simultaneous regeneration of both the bone and vasculature; mesenchymal stem cells (MSCs) are directed to replace the bone tissue, while endothelial progenitor cells (EPCs) form the new vasculature that supplies blood to the fracture site. In the elderly, the healing process is slowed, partly due to decreased regenerative function of these stem and progenitor cells. MSCs from older individuals are impaired with regard to cell number, proliferative capacity, ability to migrate, and osteochondrogenic differentiation potential. The proliferation, migration and function of EPCs are also compromised with advanced age. Although the reasons for cellular dysfunction with age are complex and multidimensional, reduced expression of growth factors, accumulation of oxidative damage from reactive oxygen species, and altered signaling of the Sirtuin-1 pathway are contributing factors to aging at the cellular level of both MSCs and EPCs. Because of these geriatric-specific issues, effective treatment for fracture repair may require new therapeutic techniques to restore cellular function. Some suggested directions for potential treatments include cellular therapies, pharmacological agents, treatments targeting age-related molecular mechanisms, and physical therapeutics. Advanced age is the primary risk factor for a fracture, due to the low bone mass and inferior bone quality associated with aging; a better understanding of the dysfunctional behavior of the aging cell will provide a foundation for new treatments to decrease healing time and reduce the development of complications during the extended recovery from fracture healing in the elderly.

Indexed as

AgingAngiogenesisBoneEndothelial progenitor cellsFracture healingMesenchymal stem cells

Identifiers

PMID31293713
PMCPMC6600851
OpenAlexW2955032361

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.